[go: up one dir, main page]

PE20050973A1 - Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos - Google Patents

Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos

Info

Publication number
PE20050973A1
PE20050973A1 PE2004001027A PE2004001027A PE20050973A1 PE 20050973 A1 PE20050973 A1 PE 20050973A1 PE 2004001027 A PE2004001027 A PE 2004001027A PE 2004001027 A PE2004001027 A PE 2004001027A PE 20050973 A1 PE20050973 A1 PE 20050973A1
Authority
PE
Peru
Prior art keywords
naphthalen
piperidine
salt
pyridylmethyl
antagonists
Prior art date
Application number
PE2004001027A
Other languages
English (en)
Inventor
Julie Congdon
Mathai Mammen
Robert Chao
Richard D Wilson
Weijiang Zhang
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of PE20050973A1 publication Critical patent/PE20050973A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/33—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of six-membered aromatic rings being part of condensed ring systems
    • C07C309/34—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of six-membered aromatic rings being part of condensed ring systems formed by two rings
    • C07C309/35—Naphthalene sulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A UNA SAL DE ACIDO NAFTALEN-1,5-DISULFONICO DE 4-{N-[7-(3-(S)-1-CARBAMIL-1,1-DIFENILMETIL)PIRROLIDIN-1-IL]-N-(ISOPROPIL)MINO}-1-(4-METOXIPIRID-3-ILMETIL)PIPERIDINA DONDE LA SAL TIENEN UNA RELACION MOLAR ENTRE ACIDO NAFTALEN-1,5-DISULFONICO Y 4-{N-[7-(3-(S)-1-CARBAMIL-1,1-DIFENILMETIL)PIRROLIDIN-1-IL]-N-(ISOPROPIL)MINO}-1-(4-METOXIPIRID-3-ILMETIL)PIPERIDINA QUE VARIA ENTRE 0,7 Y 1,1. LA SAL ES UN POLVO AMORFO QUE SE CARACTERIZA POR UN ESPECTRO FTIR QUE TIENE PICOS EN 1671,7; 1593,5; 1497,6; 1291,2; 1220,9; 1180,3 Y 1030,1 CM-1 Y UNA PUREZA DE MAYOR DE 98% EN PESO. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA Y A UN PROCESO DE PREPARACION. DICHA SAL ES ANTAGONISTA DEL RECEPTOR MUSCARINICO UTIL EN EL TRATAMIENTO DE VEJIGA SUPERACTIVA
PE2004001027A 2003-10-29 2004-10-26 Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos PE20050973A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51539403P 2003-10-29 2003-10-29

Publications (1)

Publication Number Publication Date
PE20050973A1 true PE20050973A1 (es) 2005-11-19

Family

ID=34549405

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004001027A PE20050973A1 (es) 2003-10-29 2004-10-26 Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos

Country Status (9)

Country Link
US (1) US20050113413A1 (es)
EP (1) EP1680416A2 (es)
JP (1) JP2007509967A (es)
CN (1) CN1875017A (es)
AR (1) AR046427A1 (es)
CA (1) CA2543012A1 (es)
PE (1) PE20050973A1 (es)
TW (1) TW200530220A (es)
WO (1) WO2005042514A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
TW200510298A (en) * 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
EP1725525A1 (en) * 2004-03-11 2006-11-29 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
WO2005087763A1 (en) * 2004-03-11 2005-09-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) * 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
TW200628465A (en) * 2004-10-28 2006-08-16 Theravance Inc Process for preparing substituted 4-amino-1-(pyridylmethyl) piperidine and related compounds
US7880007B2 (en) * 2004-11-29 2011-02-01 Vertex Pharmaceuticals Incorporated Bicyclic substituted phenyl piperidine modulators of muscarinic receptors
TWI372749B (en) 2005-03-10 2012-09-21 Theravance Inc Crystalline forms of a biphenyl compound
WO2006099166A1 (en) * 2005-03-10 2006-09-21 Theravance, Inc. Crystalline forms of a biphenyl compound
WO2006105035A2 (en) 2005-03-28 2006-10-05 Vertex Pharmaceuticals Incorporated Muscarinic modulators
US7973055B2 (en) * 2006-03-09 2011-07-05 Theravance, Inc. Crystalline forms of a biphenyl compound
ES2306595B1 (es) * 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
MX2012000682A (es) 2009-07-15 2012-02-28 Theravance Inc Formas de bases libres cristalinas de un compuesto de bifenilo.
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2425983C3 (de) * 1973-06-12 1978-09-14 Toyama Chemical Co. Ltd., Tokio Sulfonsäuresalze von Acylcholinen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzung
US6693202B1 (en) * 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
UA73543C2 (uk) * 1999-12-07 2005-08-15 Тераванс, Інк. Похідні сечовини, фармацевтична композиція та застосування похідного при приготуванні лікарського засобу для лікування захворювання, яке опосередковується мускариновим рецептором
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
WO2005007645A1 (en) * 2003-07-11 2005-01-27 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds

Also Published As

Publication number Publication date
CN1875017A (zh) 2006-12-06
EP1680416A2 (en) 2006-07-19
CA2543012A1 (en) 2005-05-12
JP2007509967A (ja) 2007-04-19
WO2005042514A3 (en) 2006-01-19
WO2005042514A2 (en) 2005-05-12
US20050113413A1 (en) 2005-05-26
AR046427A1 (es) 2005-12-07
TW200530220A (en) 2005-09-16

Similar Documents

Publication Publication Date Title
PE20050973A1 (es) Sales de acido naftalen-1,5-disulfonico de un compuesto de 4-amino-1-(piridilmetil)piperidina como antagonistas de receptores muscarinicos
PE20080186A1 (es) Derivados 4,6-disustituidos de 2-metoxi-6-etilamino-pirimidina como antagonistas del receptor de prostaglandina d2
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
JP5833804B2 (ja) Ｎｏｓ阻害活性を有する置換インドール化合物
EA200300919A1 (ru) N-замещенные неарильные гетероциклические антагонисты nmda/nr2b
CY1112011T1 (el) Παραγωγα αζαδικυκλο (3.1.0) εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης
EA201070091A1 (ru) Производные пиперидина, пригодные в качестве антагонистов рецептора орексина
PE20120006A1 (es) Compuestos derivados de pirimidina como inhibidores de la quinasa aurora
NL1030324C2 (nl) Sulfonylbenzimidazoolderivaten.
SA05260205B1 (ar) منع فقدان واستعادة كتلة العظم بواسطة معضدات بروستاجلاندين prostaglandin agonists معينة
PE20050525A1 (es) Derivados de pirazol sustituido y compuestos relacionados como antagonistas del receptor de bradiquinina b1
PE20091093A1 (es) Compuesto heterociclico que contiene nitrogeno y su uso
PE20091035A1 (es) Derivados de 2-aminopirimidina
KR20140124398A (ko) 오렉신 수용체 길항제로서 치환된 프롤린 / 피페리딘
SI2081572T1 (sl) Benzimidazolni kanabinoidni agonisti ki nosijo substituirano heterociklično skupino
EA200900707A1 (ru) Новый способ синтеза 7,8-диметокси-1,3-дигидро-2h-3-бензазепин-2-она, и его применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
EA200900605A1 (ru) Новые производные фенилсульфамоил бензамидов в качестве антагонистов брадикининовых рецепторов
PE20081496A1 (es) Derivados de 2,5-dihidro-3-h-pirazolo[4,3-c]piridazin-3-ona sustituidos como antagonistas de los receptores cb1
RU2014137257A (ru) Способ получения сульфилиминовых соединений
PE20060079A1 (es) DERIVADOS DE PIRIDILO COMO ANTAGONISTAS DEL RECEPTOR mGlus5
PE20110928A1 (es) Derivados de 4-azetidinil-1-heteroaril-ciclohexanol como antagonistas de ccr2
ES2159717T3 (es) Derivados de acido 5-(piperidinil-1 sustituido en posicion 4)-3-aril-pentanoico como antagonistas de los receptores de taquiquinina.
TW200726764A (en) N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
ECSP088939A (es) Carboxamidas sustituidas como antagonistas del receptor metabotropico del grupo i
CY1114377T1 (el) 5-(3,4-διχλωρο-φαινυλο)-ν-(2-υδροξυ-κυκλοεξυλο)-6-(2,2,2-τριφθορο-αιθοξυ)-νικοτιναμιδιο και αλατα αυτου ως παραγοντες που αυξανουν την hdl χοληστερολη

Legal Events

Date Code Title Description
FC Refusal